Conclusion: CEA should not be performed sooner than 2 days after stroke, but surgeons should strive to operate between 8 and 14 days after stroke to protect against postoperative stroke/death.
It's better to wait more than two days to perform carotid endarterectomy after intravenous thrombolysis administered for stroke Key findings: There were 128 carotid endarterectomies (CEAs) performed in patients who had preceding intravenous thrombolysis (IVT) for acute stroke and 777 CEAs without IVT. About two-thirds of patients underwent CEA within 14 days after IVT. There were no statistically significant differences between individual outcomes for patients who underwent CEA within 2 days after IVT compared to those who underwent surgery later than 2 days. However, stroke recurrence in IVT DEA patients was 5.5% at median 4 days after IVT (range, 0-8 days). The CEA-related stroke rate was similar to that of the operation without IVT.
Prior Intravenous Stroke Thrombolysis Does not Increase Complications of Carotid Endarterectomy
Conclusion: Time between IVT and CEA was not associated with CEA-related complications. The high rate (5.5%) of stroke recurrence during the waiting time for CEA underscores the importance of shortening surgery delays.
Commentary: This paper exemplifies why readers who simply glance at the conclusion of an abstract may believe they are coming away with some useful knowledge, but in actuality the proposed conclusion is misleading. Although there were no statistically significant differences between individual outcomes for patients who underwent CEA within 2 days after IVT compared to those who underwent surgery later than 2 days, the combined risk of postoperative ischemic stroke (5.0% vs 3.7%), hemorrhagic stroke (5.0% vs 1.9%), and hyperperfusion syndrome (20% vs 6.5%) was 30% vs 12.1% overall, respectively. Clearly, performing CEA within 2 days of IVT is riskier than waiting more than 2 days. It makes sense that operating soon after IVT would be associated with a higher chance of hemorrhagic stroke and hyperperfusion syndrome. The tradeoff of not operating soon after IVT is that 5.5% of patients developed recurrent stroke an average of 4 days after IVT administration.
Take-home message: Although there is a risk of recurrent stroke after intravenous thrombolysis to treat acute stroke, I would not perform CEA within 2 days after giving this drug. A reasonable tradeoff might be to perform CEA 3 days after thrombolysis is administered to treat acute stroke.
thoracoabdominal aneurysms (TAA-II). Patients with CKD had higher rates of operative death (13% vs. 7%; P ¼ .003), adverse events (P ¼ .01), need for dialysis (P ¼ .02), and worse 10-year survival (24% vs. 49%; P < .001) after surgery compared to those without CKD.
Conclusion: Further investigation to improve renal protection during repair of TAA-II is needed to diminish the considerable risks of operative death, adverse events, and poor long-term survival of these patients.
Commentary: There are several important points of this paper. First, a high percentage of patients, namely 40%, who underwent TAA-II repair at this institution had CKD. Second, the authors refer to previous publications supporting their use of cold crystalloid instead of blood for renal perfusion after aortic cross-clamping to decrease renal ischemia (although they continue to recommend that the celiac and superior mesenteric arteries be perfused with isothermic blood). Third, patients with CKD who received cold renal perfusion were half as likely to die as those who did not receive it. The authors do not discuss consideration of a more conservative approach for patients with TAA-II and CKD. This decision-making is always difficult and a patient-specific approach is clearly necessary. Take-home message: We should keep in mind a tenant of the Hippocratic oath: do no harm. Developing stricter guidelines for surgery for patients with type II thoracoabdominal aneurysms and chronic kidney disease may be best. Key findings: The authors treated 30 patients with 33 transabdominal direct sac puncture embolization with cyanoacrylate glue, glue/coils and onyx 6 glue/coils for type II endoleaks after endovascular abdominal aortic aneurysm repair (EVAR). This technique is particularly useful to access endoleaks anterior to the stent graft. Technical success was achieved in 97% (29/30) of patients and freedom from aneurysm growth was achieved in 85% of patients after $1 embolization procedures after a mean of 15 months follow-up. Two patients suffered small self-limiting rectus sheath hematomas and one developed neuropraxia due to a psoas muscle injury, which resolved after 6 months. There were no bowel injuries.
Sticking a needle through the belly is perfectly safe to treat type II endoleaks
Conclusion: Percutaneous transabdominal embolization is a safe and effective treatment for type II endoleaks, especially for endoleaks anterior to an aortic stent graft.
Commentary: In this study, transabdominal direct sac punctures were performed in selected patients, namely those with lumbar endoleaks and a safe route from the anterior abdominal wall to the perfused portion of the sac. Thirteen patients were excluded from the study who did not have unobstructed access or had isolated inferior mesenteric artery endoleaks. Safe access was determined based on preprocedure ultrasound imaging. Ultrasound-guided compression displaced intervening bowel by applying firm, continuous pressure to the anterior abdominal wall using the transducer during needle advancement. If there was interposed bowel despite transducer compression, transabdominal direct sac puncture was not suitable. The obvious advantage of a transabdominal direct sac puncture compared to the more commonly performed translumbar approach is the former can be performed in the supine position, which is more readily accepted by patients and less likely to be associated with airway issues, while the latter is performed in the prone position. I wonder how many of the patients in this series were obese or had other challenging anatomic characteristics that would render the technique inadvisable. I discussed this approach with an interventional radiologist with extensive experience treating type II endoleaks. Although he has done a few transabdominal direct sac punctures, he reserves the technique for rare cases when translumbar or intrarterial approaches are not possible. He also believed the risk of bleeding and infection using the transabdominal approach may be theoretically higher than a translumbar approach.
Take-home message: Transabdominal direct sac puncture may play an expanding role to treat type II endoleaks due to lumbar artery endoleaks after EVAR.
